Contact
Please use this form to send email to PR contact of this press release:
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor
TO:
Please use this form to send email to PR contact of this press release:
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor
TO: